Psilocybin therapy alongside DBT for borderline personality disorder
Treatments studied
Part of Mental health clinical trials.
This study tests whether adding psilocybin (a psychedelic drug) to your regular DBT therapy can help reduce symptoms of borderline personality disorder. Psilocybin is given during therapy sessions and may help you process emotions and improve your relationships.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of borderline personality disorder.
- You must already be in the M Health Fairview DBT program for at least one month, attending group and individual therapy regularly.
- You must be between 25 and 65 years old and speak English.
- You must be able to fill out questionnaires and follow study instructions without help.
- If you can become pregnant, you must agree to use birth control or abstain from sex during the study.
- You cannot have certain mental health conditions (like bipolar, schizophrenia, or active substance use in the past year), heart problems, or a recent suicide attempt.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a single dose of MDMA, given under supervision, can help people with borderline personality disorder (BPD). You will stay overnight after the session and be followed up for two weeks.
This study tests talk therapy for couples where one person has borderline personality disorder (BPD). It aims to see if the therapy helps improve symptoms and relationship quality.
This trial compares a therapy called mentalization-based treatment with other proven therapies for people with borderline personality disorder. It aims to find out which approach works better for reducing self-harm and suicidal behaviors.
This study tests whether a psychedelic drug called psilocybin (the active ingredient in 'magic' mushrooms), combined with therapy, can help relieve depression in people with bipolar II disorder who haven't gotten better with other treatments. You'll receive the drug in a supervised setting and attend follow-up visits to see how it affects your mood.
This study tests if psilocybin (a psychedelic) combined with cognitive behavioral therapy (CBT) can help people with major depression. You would receive the psilocybin in a supervised setting and have talk therapy before and after.
This trial tests if two doses of psilocybin, given under medical supervision, are safe and acceptable for people with Bipolar II disorder who have mild to moderate depression and certain suicidal thoughts. The goal is to see if it may help improve mood and reduce suicidal thinking.
Hear when a new Borderline Personality Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.